Project Details
Projekt Print View

Orexin’s role in mouse behavioral endophenotypes for schizophrenia

Subject Area Biological Psychiatry
Cognitive, Systems and Behavioural Neurobiology
Term from 2019 to 2022
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 424697493
 
Final Report Year 2023

Final Report Abstract

Taken together, the data from the first funding period indicate sex-dependent effects of orexin deficiency, nasal orexin, and specific OxR antagonists. Overall, male mice seem to more profit from orexin deficiency or OxR blockade while nasal orexin or chemogenetic stimulation of the orexin system had rather negative consequences. This was different in female mice, in which orexin deficiency or OxR blockade often had negative consequences. However, these statements are mainly based on our experiments regarding endophenotypes related to positive and negative symptoms of schizophrenia. Regarding endophenotypes of cognitive symptoms of schizophrenia clearly more data are needed to support these statements, especially from experiments investigating the role of OX1R and OX2R in these endophenotypes. Furthermore, the role of orexin in further cognitive functions – beyond ASST and 5-CSRTT – should be investigated. Last, we think it is crucial to test orexin-related treatments in a developmental animal model of schizophrenia.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung